Page last updated: 2024-10-30

manidipine and Symptom Cluster

manidipine has been researched along with Symptom Cluster in 1 studies

Research Excerpts

ExcerptRelevanceReference
"Manidipine is a lipophilic, third-generation, highly vasoselective, dihydropyridine (DHP) calcium channel antagonist, which, when given on a once-daily basis, effectively reduces blood pressure (BP) in patients with mild-to-moderate essential hypertension."4.82Antihypertensive effect of manidipine. ( Roca-Cusachs, A; Triposkiadis, F, 2005)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Roca-Cusachs, A1
Triposkiadis, F1

Reviews

1 review available for manidipine and Symptom Cluster

ArticleYear
Antihypertensive effect of manidipine.
    Drugs, 2005, Volume: 65 Suppl 2

    Topics: Age Factors; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channe

2005